Risk of long COVID is higher in women and a link between SARS-CoV-2 infection and development of ME/CFS is shown, according ...

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.

This cohort study showed that, during the 2022 to 2023 season, infection with SARS-CoV-2 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV), whereas ...

The following is a summary of “Current and Future Burden of Long COVID in the United States (U.S.),” published in the January ...

Distinct protein profiles linked to inflammation and angiogenesis found in children with Long COVID, paving the way for ...

Since COVID-19 first took off, political leaders, infectious disease specialists, and the lay public have debated its origins ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

A US Centers for Disease Control and Prevention (CDC)-led study identifies three clusters of post-COVID multisystem ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a "quad-demic." Here what you can do.

A study suggests that catching COVID-19 significantly raises the risk of developing ME/CFS (formerly called "chronic fatigue ...